2020
Overview
Idiopathic thrombocytopenic purpura (ITP) is a bleeding disorder characterized by a low platelet count. Platelets are important blood cells that help in blood clotting, and a shortage of platelets can lead to excessive bleeding and bruising. The term "idiopathic" refers to the fact that the cause of ITP is unknown. ITP can affect both adults and children and is more common in women than men. The condition may develop following an infection or use of certain medications, although in some cases there may be no identifiable triggering event. Symptoms of ITP include petechiae (small purple or red spots on the skin), easy bruising, nosebleeds, and bleeding gums. In severe cases, internal bleeding can occur, which can be life-threatening. Treatment for ITP depends on the severity of the condition. In some cases, the condition may not require any treatment, and platelet levels may return to normal on their own. For more severe cases, treatment may include corticosteroids, immunosuppressants, or splenectomy (removal of the spleen). Research in hematology and oncology is focused on understanding the underlying mechanisms behind disorders like ITP and developing new treatments for these conditions. This includes investigating potential genetic and environmental causes of ITP, improving the diagnosis and management of the condition, and exploring new treatment options.
Research published in this journal
3 peer-reviewed articles, ranked by relevance. Each links to its DOI.
2015
2024
How this research is being cited
The 3 articles above have been cited 2 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
Dina Ashraf Abdelhady et al. · 2025 · European Journal of Medical Research
-
2025 · European journal of medical research
A sample of recent works citing this journal's research on Idiopathic Thrombocytopenic Purpura, linking to each citing work.